News

Qualcomm announced its Q3 earnings after the bell on Thursday.

Qualcomm will report its third quarter earnings after the bell on Wednesday.

KLA's fiscal Q4 earnings beat estimates as AI infrastructure, foundry/logic and process control demand lift revenues 15.2% and strengthen its outlook.

Old Dominion Freight Line (NASDAQ:ODFL) reported higher second-quarter revenue and earnings as improving demand trends, pricing discipline and operating leverage supported results, while management said the company remains positioned to gain share as freight markets recover. Revenue rose 10.4% from

Arch Capital Group (NASDAQ:ACGL) reported second-quarter after-tax operating income of $893 million, or $2.56 per share, as all three operating segments produced what management described as strong underlying underwriting results. The insurer and reinsurer also accelerated capital returns, repurchas

LSCC heads into Q2 2026 earnings with expectations for higher revenues and EPS as demand for low-power FPGAs, AI servers and industrial markets supports growth.

VRNS tops Q2 earnings and revenue estimates as SaaS growth, AI security demand and a higher full-year outlook fuel confidence in its growth trajectory.

AAPL's fiscal Q3 sales may gain from strong iPhone 17 demand, while Mac growth offsets tougher iPad comparisons and supply limits.

ODFL's Q2 earnings rise 32.3% as stronger yield, cost discipline and margin gains offset continued freight-volume pressure.

NXPI posts Q2 earnings and revenue beats as automotive, industrial and AI data center demand lift growth, with strong Q3 guidance adding momentum.

Meta has fallen in the last nine trading sessions, but the streak looks ready to come to an end.

GSK beats Q2 earnings and revenue estimates, reaffirms 2026 guidance and unveils a new cost-saving plan.

Strategy faces Q2 earnings volatility as an $8.32B digital-asset loss, financing costs and dilution risks cloud its vast Bitcoin exposure.

FANG to report Q2 earnings on Aug. 3, as higher costs and weak gas prices weigh, while strong oil output and efficiency gains could support results.

Ram, Jeep, and Fiat parent company Stellantis reported decent first-half results on Thursday morning, but only reaffirmed its prior guidance. Investors clearly want more from CEO Antonio Filosa's turnaround plan.

Ram, Jeep, and Fiat parent company Stellantis will report second quarter and first half results on Thursday morning, with the success of CEO Antonio Filosa's turnaround plan clearly in focus.

The company reported a 557% annual increase in operating income in the second quarter.

Two trading sessions reached opposite conclusions about the same report. One of them had the better argument.

Starbucks aims to keep its growth story piping hot when it reports third quarter results as CEO Brian Niccol leads the company into year three of its turnaround plan.

GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.

All three major US stock indexes were down in late-morning trading Wednesday after President Trump v

BAND tops Q2 estimates as AI-driven communications demand, enterprise wins and higher guidance signal accelerating platform growth.

JCI beats third-quarter estimates with double-digit organic growth in key markets and raises its fiscal 2026 outlook on strong operating momentum.

V posts Q3 earnings and revenue beats as cross-border volumes, spending trends and network activity drive double-digit growth.

Arch Capital beats Q2 earnings estimates as investment income offsets catastrophe pressure, despite lower premiums and underwriting profit.

IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.

The headline numbers for HudBay Minerals (HBM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Q2 Earnings Season in Full Swing

SNAP heads into Q2 earnings with ad growth and AI tools in focus as geopolitical, restructuring and hardware pressures test results.

Pfizer heads into Q2 earnings with expectations for growth in key products, COVID headwinds, and guidance updates that could shape its outlook.